RRAS and neoplasm: Ras-induced tumor progression was supported by MAPK-deficient, PI3K-competent H-Ras-tR, but not by R-Ras-tH, which showed weak activation of PI3K, and Ras tumor progression was blocked in all cases by inhibition of PI3K.